091990 — Celltrion Healthcare Co Share News
0.000.00%
HealthcareAdventurousLarge Cap
- KR₩12tn
- KR₩12tn
- KR₩2tn
Brief: Celltrion Presents Efficacy And Safety Data For Potential COVID-19 Treatment Candidate CT-P59 In Patients With Mild Symptoms
S.Korea's Celltrion jumps on contract to distribute COVID-19 test kits in U.S.
S.Korea pharma Celltrion's COVID test gets U.S. emergency use authorisation
K-Pop group BTS' label Big Hit Entertainment prices IPO at top of range (updated)
S.Korea pharma Celltrion affiliates jump on merger announcement
S.Korea's Celltrion to merge with affiliates to set up holding company structure
Brief: Celltrion Launches Human Clinical Trial Of Potential Covid-19 Antiviral Antibody Treatment Following Positive Pre-Clinical Results
Brief: Celltrion: Signs Supply Contract Worth $142 Mln With Celltrion Healthcare To Provide Biosimilar Products
S.Korea's Celltrion surges; co's Remicade copy to be tested for COVID-19 treatment
S.Korea's Celltrion says COVID-19 drug shows drop in viral load in animal testing (updated)
S.Korea's Celltrion says COVID-19 drug shows 100-fold reduction in viral load
Brief: Teva And Celltrion Healthcare Announce Launch Of TRUXIMA Injection
Celltrion shares drop after Temasek block sale
Brief: Teva And Celltrion Healthcare Announce U.S. Availability Of Herzuma For Injection
Brief: Celltrion Says Internally Considering Merger Of Its Affiliates, But Nothing Has Been Decided
S.Korean stocks climb amid cautious optimism after Sino-U.S. trade deal
S.Korea's Celltrion, affiliates jump as chairman hints at merger
Brief: Teva And Celltrion Announce The Availability Of Truxima
S.Korea stocks drop on weak pharma shares; GDP data misses estimates